Abstract
Outcomes of Patients with Relapsed/Refractory Double Expressor B Cell Lymphoma As Defined By Multicenter Pathology Review Treated with Ibrutinib Monotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have